Intellia Therapeutics Inc (NTLA)
EBITDA
-$104.55M
Quarterly · Period ending: · USD
NTLA EBITDA
Latest reported-$104.55Mperiod ending
Latest reported-$104.55Mperiod ending
NTLA Quarterly EBITDA ($0.00 → -$104.55M)
Quarterly EBITDA
High-resolution chart · PNG
NTLA ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -104,552,000 | |
| -94,029,000 | |
| -95,409,000 | |
| -96,388,000 | |
| -98,781,000 | |
| -111,831,000 | |
| -126,332,000 | |
| -133,104,000 | |
| -144,376,000 | |
| -104,924,000 | |
| -129,695,000 | |
| -119,934,000 | |
| -121,511,000 | |
| -101,076,000 | |
| -111,376,000 | |
| -111,279,000 | |
| -98,841,000 | |
| -145,118,000 | |
| -79,357,000 | |
| -69,858,000 | |
| -67,172,000 | |
| -44,834,000 | |
| -40,797,000 | |
| -26,500,000 | |
| -31,468,000 | |
| -31,507,000 | |
| -28,188,000 | |
| -23,945,000 | |
| -26,122,000 | |
| -22,509,000 | |
| -19,519,000 | |
| -22,947,000 | |
| -22,522,000 | |
| -21,418,000 | |
| -23,882,000 | |
| -15,085,000 | |
| -15,306,000 | |
| -12,288,000 | |
| -10,417,000 | |
| -7,432,000 | |
| -6,699,000 | |
| -6,507,000 | |
| -5,359,000 | |
| -3,205,000 | |
| -3,355,000 | |
| -1,162,000 | |
| -4,184,500 | |
| 0 |